Aimee Mulhearn
Physician Assistant · Lake Charles, LANPI 1114366325
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.8% of the total across 710 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by GSK at 25.8% of the total. Among physician assistant clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 710 payments — averaging $19.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$4K
- AstraZeneca$3K
- Sanofi$2K
- Regeneron Healthcare Solutions, Inc.$977
- Mylan Specialty L.p.$933
- CSL Behring$859
- plus $2K from 18 others
What the payments were for
- Food & beverage$13,40898%
- Education$3032%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 224 | $3,531 |
| AstraZeneca | 158 | $3,272 |
| Sanofi | 73 | $1,780 |
| Regeneron Healthcare Solutions, Inc. | 37 | $977 |
| Mylan Specialty L.p. | 57 | $933 |
| CSL Behring | 39 | $859 |
| Boehringer Ingelheim | 23 | $402 |
| Insmed, Inc. | 13 | $277 |
| Baxter Healthcare | 12 | $266 |
| Amgen | 12 | $249 |
| Viatris Specialty LLC | 15 | $232 |
| Bayer | 11 | $184 |
| Grifols USA, LLC | 7 | $139 |
| United Therapeutics Corporation | 6 | $103 |
| Sanofi-aventis U.S. LLC | 1 | $97 |
| Verona Pharma, Inc. | 5 | $89 |
| Advanced Respiratory, Inc | 4 | $76 |
| Philips North America LLC | 4 | $57 |
| Sunovion Pharmaceuticals Inc. | 2 | $47 |
| Boston Scientific | 1 | $41 |
| Merck | 2 | $35 |
| Actelion Pharmaceuticals US, Inc. | 2 | $33 |
| Tactile Systems Technology Inc | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,711 in reported general payments places this provider in the 95th percentile of 1,246 physician assistant providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 756 | $915,910 |
| Dupixent PenDupilumab | 48 | $197,293 |
| OfevNintedanib Esylate | 15 | $195,256 |
| Fasenra PenBenralizumab | 32 | $187,466 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 74 | $63,044 |
| Spiriva RespimatTiotropium Bromide | 64 | $53,286 |
| Breo ElliptaFluticasone/Vilanterol | 65 | $50,577 |
| SymbicortBudesonide/Formoterol Fumarate | 105 | $38,978 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 551 | $21,887 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 37 | $20,227 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 96 | $19,255 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 21 | $19,207 |
| Roflumilast | 199 | $18,850 |
| Spiriva HandihalerTiotropium Bromide | 17 | $18,099 |
| Advair HfaFluticasone Propion/Salmeterol | 17 | $13,420 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta, Arnuity Ellipta | $3,531 | $1,005,977903 claims |
| Boehringer IngelheimOfev, Spiriva Respimat, Stiolto Respimat, Combivent Respimat | $402 | $273,976113 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $3,272 | $102,022179 claims |
| MerckDulera | $35 | $6,17815 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,246 physician assistant providers in Louisiana.
Other physician assistant in Lake Charles
- Shelly EsnardBaton Rouge$141K
- Jefferson OberleNew Orleans$66K
- Jennifer ScheuermannNew Orleans$56K
- Claire DarreJefferson$50K
- Elizabeth ClementNew Orleans$35K
- Mary Negrotto GuntherSlidell$29K
- Kristen HebertZachary$27K
- David GsellNew Orleans$26K
- Nakia BrooksNew Orleans$25K
- Savannah SanchezBaton Rouge$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.